Therapy to Reduce dementia risk In Parkinson's disease (TRIP): Proof-of-concept trial

被引：0
|
作者：
Pourzinal, D.
Bakker, A.
Byrne, G.
McMahon, K.
O'Sullivan, J.
Adam, R.
Lehn, A.
Copland, D.
Yang, J.
Pontone, G.
Au, T.
Littleford, R.
Chatfield, M.
Mari, Z.
Dissanayaka, N.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
434
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [41] Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
    Kunadian, Vijay
    Wilson, Nina
    Stocken, Deborah D.
    Ali, Hani
    McColl, Elaine
    Burns, Graham
    Howe, Nicola
    Fisher, Andrew
    De Soyza, Anthony
    ERJ OPEN RESEARCH, 2019, 5 (03)
  • [42] In search of proof-of-concept: gene therapy for glycogen storage disease type Ia
    Koeberl, Dwight D.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 (04) : 671 - 678
  • [43] Risk factors for dementia in Parkinson's disease
    Opala, G
    Jasinska-Myga, B
    Ochudlo, S
    Tustanowski, J
    MOVEMENT DISORDERS, 2002, 17 : S145 - S145
  • [44] Risk Factors for Dementia in Parkinson's disease
    Khalil, M. I.
    Rahman, M. R.
    Munira, S.
    MOVEMENT DISORDERS, 2017, 32
  • [45] Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia
    Olincy, Ann
    Harris, Josette G.
    Johnson, Lynn L.
    Pender, Vicki
    Kongs, Susan
    Allensworth, Diana
    Ellis, Jamey
    Zerbe, Gary O.
    Leonard, Sherry
    Stevens, Karen E.
    Stevens, James O.
    Martin, Laura
    Adler, Lawrence E.
    Soti, Ferenc
    Kem, William R.
    Freedman, Robert
    ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (06) : 630 - 638
  • [46] Buzz around Campath proof-of-concept trial in MS
    Randy Osborne
    Nature Biotechnology, 2009, 27 : 6 - 8
  • [47] Engineering a "three-in-one" hirudin prodrug to reduce bleeding risk: A proof-of-concept study
    Zhu, Yuanjun
    Han, Hu-Hu
    Zhai, Lin
    Yan, Yi
    Liu, Xiaoyan
    Wang, Yinye
    Lei, Liandi
    Wang, Jian-Cheng
    JOURNAL OF CONTROLLED RELEASE, 2021, 338 : 462 - 471
  • [48] Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia
    Christine E. Marx
    Jimmy Lee
    Mythily Subramaniam
    Attilio Rapisarda
    Dianne C. T. Bautista
    Edwin Chan
    Jason D. Kilts
    Robert W. Buchanan
    Eu Pui Wai
    Swapna Verma
    Kang Sim
    Jayaraman Hariram
    Rajesh Jacob
    Richard S. E. Keefe
    Siow Ann Chong
    Psychopharmacology, 2014, 231 : 3647 - 3662
  • [49] The Evaluation of Proof-of-Concept Trial Design for Compound Selection
    Lu, Jiandong
    Dong, Bin
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (04): : 315 - 320
  • [50] Proof-Of-Concept Randomized Controlled Trial of Pregnenolone in Schizophrenia
    Marx, Chris
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 116S - 116S
12345